Results 81 to 90 of about 2,534,683 (266)

Pure state thermodynamics with matrix product states

open access: yes, 2013
We extend the formalism of pure state thermodynamics to matrix product states. In pure state thermodynamics finite temperature properties of quantum systems are derived without the need of statistical mechanics ensembles, but instead using typical ...
Garnerone, Silvano
core   +1 more source

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

open access: yesMolecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice   +16 more
wiley   +1 more source

The Product Structure of Matrix Product States under Permutations

open access: yesPRX Quantum
Tensor network methods have proved to be highly effective in addressing a wide variety of physical scenarios, including those lacking an intrinsic one-dimensional geometry.
Marta Florido-Llinàs   +5 more
doaj   +1 more source

Heat current in non-Markovian open systems

open access: yesNew Journal of Physics, 2023
We generalize time-evolving matrix product operators method to nonequilibrium quantum transport problems. The nonequilibrium current is obtained via numerical differentiation of the generating functional which is represented as a tensor network.
Ruofan Chen
doaj   +1 more source

Lower Bounds for Matrix Product [PDF]

open access: yesSIAM Journal on Computing, 2001
We prove lower bounds on the number of product gates in bilinear and quadratic circuits that compute the product of two $n \cross n$ matrices over finite fields. In particular we obtain the following results: 1. We show that the number of product gates in any bilinear (or quadratic) circuit that computes the product of two $n \cross n$ matrices over ...
openaire   +2 more sources

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Dense QCD2 with matrix product states

open access: yesJournal of High Energy Physics
We study one-flavor SU(2) and SU(3) lattice QCD in (1 + 1) dimensions at zero temperature and finite density using matrix product states and the density matrix renormalization group.
Tomoya Hayata   +2 more
doaj   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy